Cite
HARVARD Citation
Nakamura, N. et al. (n.d.). Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B‐cell lymphoma treated with the R‐CHOP regimen. European journal of haematology. pp. 322-331. [Online].